Whereas an upregulation of PD-L1 expression on CRT was hypothesized, our data did not demonstrate a corresponding increase in [89Zr]Zr-durvalumab uptake in the tumor at 1-week on-treatment nor at the end of treatment. This evidence concerns the gene CD274 and neoplasm.